Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 26, 2002BloodOpen Access

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

View Full Paper
Ask AI
Bookmark
Share

Authors

SRStephen RobinsonIntel (United States)AGAnthony H. GoldstoneNorthwestern UniversitySMStephen MackinnonNational Health Service

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Robinson et al. (2002) studied this question.

synapsesocial.com/papers/6a1ef1cb08df8bb755b2f656https://doi.org/10.1182/blood-2001-11-0107
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation2001 · 516 citations
  2. 2Allogeneic bone marrow transplantation for low-grade lymphoma.1998 · 265 citations
  3. 3Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy1997 · 1,152 citations